The expression and significance of IDH1 and p53 in osteosarcoma

The expression and significance of IDH1 and p53 in osteosarcoma

<p>Abstract</p> <p>Background</p> <p>To detect the expression of isocitrate dehydrogenase 1 (IDH1) and transformation-related protein 53 (p53) in osteosarcoma and analyze the correlation between them and the clinico-pathological features.</p> <p>Methods</...

Full description

Bibliographic Details
Main Authors:	Zhou Min, Wu Gang, Fu Tao, Qi Bai-Wen, Yu Ai-Xi, Hu Xiang, Luo Jun, Xu Jun-Hua
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	Journal of Experimental & Clinical Cancer Research
Online Access:	http://www.jeccr.com/content/29/1/43

Similar Items

Severe cellular stress activates apoptosis independently of p53 in osteosarcoma
by: Cheng-Jung Ho, et al.
Published: (2021-10-01)

Expression of IDH1, ATRX, p53 in Diagnosis of Gliomas as Per 2016 WHO Classification
by: Lokesh Kumar, et al.
Published: (2023-07-01)

The relationship between IDH, P53 mutations, MGMT methylation with characteristics in high grade glioma patients
by: Duc Anh Tran, et al.
Published: (2022-07-01)

TP53 in Biology and Treatment of Osteosarcoma
by: Kamil Jozef Synoradzki, et al.
Published: (2021-08-01)

p53 inhibits CTR1-mediated cisplatin absorption by suppressing SP1 nuclear translocation in osteosarcoma
by: Lei Yong, et al.
Published: (2023-01-01)

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma.
by: Anup K Kundu, et al.
Published: (2017-01-01)

A Simple Panel of IDH1 and P53 in Differential Diagnosis Between Low-Grade Astrocytoma and Reactive Gliosis
by: Bita Geramizadeh, et al.
Published: (2021-02-01)

AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma
by: Diwei Zheng, et al.
Published: (2021-01-01)

Clinical significance of p53 protein expression and TP53 variation status in colorectal cancer
by: Kyoung Min Kim, et al.
Published: (2022-08-01)

Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells
by: Heena Saini, et al.
Published: (2021-01-01)

Molecular classification of glioblastoma based on immunohistochemical expression of EGFR, PDGFRA, NF1, IDH1, p53 and PTEN proteins
by: Sylwia Jankowska, et al.
Published: (2021-05-01)

Clinical characteristics and MRI features of IDH⁃mutant in insular glioma
by: ZHANG Zi⁃feng, et al.
Published: (2022-05-01)

The regulatory effects of p53 on the typical and atypical ferroptosis in the pathogenesis of osteosarcoma: A systematic review
by: Linfeng Wang, et al.
Published: (2023-03-01)

The biological function and clinical significance of STIL in osteosarcoma
by: Shu-fan Ji, et al.
Published: (2021-04-01)

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors
by: Santosh Sharma, et al.
Published: (2023-08-01)

Prognostic Significance of p53 Expression in Breast Carcinoma
by: صفاء قطليش, et al.
Published: (2023-01-01)

Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
by: Hye Jung Hwang, et al.
Published: (2020-09-01)

Clinical significance of CCL2 expression in osteosarcoma tissue
by: GONG Runze, HU Haiyan
Published: (2021-06-01)

Global effect of inauhzin on human p53-responsive transcriptome.
by: Jun-Ming Liao, et al.
Published: (2012-01-01)

Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
by: Mingzhe Li, et al.
Published: (2022-10-01)

Discovery and Characterization of Intercondylar Transphyseal Complexes and their Oncological Significance in Transphyseal Extension of Pediatric Osteosarcoma
by: Xian‐hao Shao, et al.
Published: (2022-02-01)

ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway
by: Yanqin Zhang, et al.
Published: (2018-07-01)

Clonality analysis and IDH1 and IDH2 mutation detection in both components of dedifferentiated chondrosarcoma, implicated its monoclonal origin
by: Tingting Yang, et al.
Published: (2020-06-01)

Impairment of rigidity sensing caused by mutant TP53 gain of function in osteosarcoma
by: Ming Luo, et al.
Published: (2023-05-01)

Evaluation of genetic alterations of IDH1, TP53 and CASP9 genes as biomarkers in glioma patients
by: Yit, Pua Jing
Published: (2022)

The p53-mediated cell cycle regulation is a potential mechanism for emodin-suppressing osteosarcoma cells
by: Qian Zhang, et al.
Published: (2024-03-01)

Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline
by: Sergei Boichuk, et al.
Published: (2023-08-01)

Expression of P53, PTEN and S100A4 in invasive ductal breast cancer and the clinical significance
by: Zhang Gang
Published: (2015-05-01)

The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma
by: Min Zhou, et al.
Published: (2012-12-01)

Research progress of IDH1 and IDH2 mutations in gliomas
by: Shan-shan ZHANG, et al.
Published: (2015-11-01)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01)

Significance of p53 and ki-67 expression in prostate cancer
by: Renuka Verma, et al.
Published: (2015-01-01)

Expression and clinical significance of IBP and p53 in gastric adenocarcinoma
by: KANG Xia, et al.
Published: (2019-02-01)

The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V
by: Xu Sun, et al.
Published: (2022-02-01)

Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
by: Krell, D, et al.
Published: (2011)

Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
by: Daniel Krell, et al.
Published: (2011-01-01)

p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
by: Chiara Novello, et al.
Published: (2014-01-01)

Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance
by: Mannu K Walia, et al.
Published: (2016-04-01)

Isocitrate Dehydrogenase (IDH1) and p53 Mutations in Gliomas: A Cross-sectional Study from a Tertiary Care Hospital, Karnataka, India
by: Nissy J Louis, et al.
Published: (2023-06-01)

Prognostic significance of modified lung immune prognostic index in osteosarcoma patients
by: Xuanhong He, et al.
Published: (2022-10-01)